ROMIPLOSTIM Side Effects

6969476-X | Ischaemic Stroke
on Aug 31, 2010 Male patient from AUSTRALIA , weighting 132.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: ischaemic stroke. Romiplostim dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), PROCTOSEDYL (View Proctosedyl Review and Proctosedyl Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6930602-X | Deep Vein Thrombosis
Patient was taking Romiplostim (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Aug 16, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 116.8 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with PENICILLIN V (View Penicillin V Review and Penicillin V Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6832920-2 | Ischaemic Stroke, Pulmonary Arteriopathy, Pulmonary Hilum Mass
Adverse event was reported on Jul 06, 2010 by a Female patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 132.3 lb, After Romiplostim was administered, patient had the following side effects: ischaemic stroke, pulmonary arteriopathy, pulmonary hilum mass. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DEFEROXAMINE MESYLATE (View Deferoxamine Mesylate Review and Deferoxamine Mesylate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PENTASA (View Pentasa Review and Pentasa Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ). Patient was hospitalized.

6832835-X | Bicytopenia, Myelofibrosis
on Jul 06, 2010 Male patient from CANADA , weighting 191.8 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: bicytopenia, myelofibrosis. Romiplostim dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).


6813059-9 | Ischaemic Stroke, Pulmonary Arteriopathy, Pulmonary Hilum Mass
on Jun 23, 2010 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Romiplostim (View Usage). Patient had the following side effects: ischaemic stroke, pulmonary arteriopathy, pulmonary hilum mass. Romiplostim dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DEFEROXAMINE MESYLATE (View Deferoxamine Mesylate Review and Deferoxamine Mesylate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PENTASA (View Pentasa Review and Pentasa Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ). Patient was hospitalized.

6768838-3 | Ischaemic Stroke, Pulmonary Arteriopathy, Pulmonary Hilum Mass
Patient was taking Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: ischaemic stroke, pulmonary arteriopathy, pulmonary hilum mass on Jun 02, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with myelodysplastic syndrome and. Romiplostim dosage: . During the same period patient was treated with ROMIPLOSTIM STUDY PROCEDURE (View Romiplostim - Study Procedure Review and Romiplostim - Study Procedure Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DEFEROXAMINE MESYLATE (View Deferoxamine Mesylate Review and Deferoxamine Mesylate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PENTASA (View Pentasa Review and Pentasa Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ). Patient was hospitalized.

6757061-4 | Anaemia, Vaginal Haemorrhage
Adverse event was reported on May 27, 2010 by a Female patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: UNITED STATES , weighting 216.5 lb, Patient experienced the following unwanted or unexpected effects: anaemia, vaginal haemorrhage. During the same period patient was treated with AMICAR (View Amicar Review and Amicar Label ), IRON (View Iron Review and Iron Label ), YASMIN (View Yasmin Review and Yasmin Label ). Patient was hospitalized.

6732796-8 | Overdose
on May 10, 2010 Female patient from FRANCE , 55 years of age, weighting 127.9 lb, was diagnosed with thrombocytopenia and was treated with Romiplostim (View Usage). Patient had the following side effects: overdose. Romiplostim dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NALTREXONE HYDROCHLORIDE (View Naltrexone Hydrochloride Review and Naltrexone Hydrochloride Label ).

6717483-4 | Temporal Lobe Epilepsy
on May 03, 2010 Male patient from ITALY , weighting 183.0 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: temporal lobe epilepsy. Romiplostim dosage: .

6694970-9 | Pulmonary Embolism
Patient was taking Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Apr 16, 2010 from ITALY Additional patient health information: Male patient , weighting 207.2 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6693052-X | Temporal Lobe Epilepsy
Adverse event was reported on Apr 20, 2010 by a Male patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: ITALY , weighting 183.0 lb, Patient had the following side effects: temporal lobe epilepsy.

6664774-1 | Anaemia, Anisocytosis, Hypochromasia, Polychromasia, Vaginal Haemorrhage
on Mar 25, 2010 Female patient from UNITED STATES , weighting 216.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: anaemia, anisocytosis, hypochromasia, polychromasia, vaginal haemorrhage. Romiplostim dosage: . During the same period patient was treated with AMICAR (View Amicar Review and Amicar Label ), IRON (View Iron Review and Iron Label ), YASMIN (View Yasmin Review and Yasmin Label ). Patient was hospitalized.

6659679-6 | Pulmonary Embolism
on Mar 20, 2010 Male patient from ITALY , weighting 207.2 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Romiplostim dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6590372-4 | Bone Pain, Nausea, Pneumonia
Patient was taking Romiplostim (View Usage). Patient had the following side effects: bone pain, nausea (What is nausea?), pneumonia (What is pneumonia?) on Feb 10, 2010 from CANADA Additional patient health information: Female patient , weighting 114.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with COLACE (View Colace Review and Colace Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), FLAGYL (View Flagyl Review and Flagyl Label ), ATIVAN (View Ativan Review and Ativan Label ), IRON (View Iron Review and Iron Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), STEMETIL (View Stemetil Review and Stemetil Label ), STATEX (View Statex Review and Statex Label ). Patient was hospitalized.

6571776-2 | Anaemia, Vaginal Haemorrhage
Adverse event was reported on Jan 26, 2010 by a Female patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: UNITED STATES , weighting 216.5 lb, After Romiplostim was administered, patient had the following side effects: anaemia, vaginal haemorrhage. During the same period patient was treated with AMICAR (View Amicar Review and Amicar Label ), IRON (View Iron Review and Iron Label ), YASMIN (View Yasmin Review and Yasmin Label ). Patient was hospitalized.

6525662-4 | Portal Vein Thrombosis, Thrombocytopenia
on Dec 29, 2009 Female patient from BELGIUM , weighting 132.3 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: portal vein thrombosis, thrombocytopenia. Romiplostim dosage: . Patient was hospitalized.

6449602-1 | Mouth Haemorrhage
on Nov 12, 2009 Male patient from JAPAN , weighting 101.4 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient had the following side effects: mouth haemorrhage. Romiplostim dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ), MYSLEE (View Myslee Review and Myslee Label ), VESICARE (View Vesicare Review and Vesicare Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), NIZORAL (View Nizoral Review and Nizoral Label ). Patient was hospitalized.

6443871-X | Mouth Haemorrhage
Patient was taking Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: mouth haemorrhage on Nov 10, 2009 from JAPAN Additional patient health information: Male patient , weighting 101.4 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), NATEGLINIDE (View Nateglinide Review and Nateglinide Label ). Patient was hospitalized.

6441623-8 | Bleeding Peripartum, Palpitations, Ventouse Extraction
Adverse event was reported on Nov 04, 2009 by a Female patient taking Romiplostim (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: bleeding peripartum, palpitations, ventouse extraction. During the same period patient was treated with NUTRITIONAL AGENTS AND VITAMINS (View Nutritional Agents And Vitamins Review and Nutritional Agents And Vitamins Label ).

6431520-6 | Biopsy Bone Marrow Abnormal
on Oct 28, 2009 Male patient from UNITED STATES , weighting 192.0 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient had the following side effects: biopsy bone marrow abnormal. Romiplostim dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6418544-X | Biopsy Bone Marrow Abnormal
on Oct 21, 2009 Male patient from UNITED STATES , weighting 192.0 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: biopsy bone marrow abnormal. Romiplostim dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6354619-1 | Therapeutic Response Decreased
Patient was taking Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: therapeutic response decreased on Sep 07, 2009 from BELGIUM Additional patient health information: Male patient , weighting 178.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with PLATELETS (View Platelets Review and Platelets Label ).

6331557-1 | Therapeutic Response Decreased
Adverse event was reported on Aug 24, 2009 by a Male patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: BELGIUM , weighting 178.6 lb, Patient had the following side effects: therapeutic response decreased.

6275389-1 | Acute Coronary Syndrome
on Jul 15, 2009 Male patient from ITALY , weighting 149.9 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: acute coronary syndrome. Romiplostim dosage: . During the same period patient was treated with ANTRA (View Antra Review and Antra Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6267070-X | Accidental Overdose, Incorrect Dose Administered, Thrombocytosis
on Jul 07, 2009 Female patient from FRANCE , weighting 220.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, incorrect dose administered, thrombocytosis. Romiplostim dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ATACAND (View Atacand Review and Atacand Label ).

6267058-9 | Chronic Lymphocytic Leukaemia
Patient was taking Romiplostim (View Usage). Patient had the following side effects: chronic lymphocytic leukaemia on Jul 07, 2009 from FRANCE Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: .

6253005-2 | Acute Coronary Syndrome
Adverse event was reported on Jun 25, 2009 by a Male patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: ITALY , weighting 149.9 lb, After Romiplostim was administered, patient had the following side effects: acute coronary syndrome. During the same period patient was treated with ANTRA (View Antra Review and Antra Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6239607-8 | Chronic Lymphocytic Leukaemia
on Jun 15, 2009 Male patient from FRANCE , weighting 167.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: chronic lymphocytic leukaemia. Romiplostim dosage: .

6235244-X | Acute Coronary Syndrome
on Jun 11, 2009 Male patient from ITALY , weighting 149.9 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient had the following side effects: acute coronary syndrome. Romiplostim dosage: . During the same period patient was treated with ANTRA (View Antra Review and Antra Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6222945-2 | Therapeutic Response Decreased
Patient was taking Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: therapeutic response decreased on Jun 03, 2009 from FRANCE Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), MABTHERA (View Mabthera Review and Mabthera Label ), NEORAL (View Neoral Review and Neoral Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CELIPROLOL (View Celiprolol Review and Celiprolol Label ), PNEUMOCOCCAL VACCINE (View Pneumococcal Vaccine Review and Pneumococcal Vaccine Label ), INFLUENZA VACCINE (View Influenza Vaccine Review and Influenza Vaccine Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6215937-0 | Epistaxis
Adverse event was reported on May 28, 2009 by a Male patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: UNITED STATES , weighting 151.2 lb, Patient experienced the following unwanted or unexpected effects: epistaxis. Patient was hospitalized.

6214392-4 | Angina Unstable, Stent Placement
on May 28, 2009 Male patient from BELGIUM , weighting 165.3 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient had the following side effects: angina unstable, stent placement. Romiplostim dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

6208446-6 | Chronic Lymphocytic Leukaemia
on May 25, 2009 Male patient from FRANCE , weighting 167.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: chronic lymphocytic leukaemia. Romiplostim dosage: .

6200547-1 | Angina Unstable, Stent Placement
Patient was taking Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, stent placement on May 13, 2009 from BELGIUM Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . Patient was hospitalized.

6184536-1 | Chronic Lymphocytic Leukaemia
Adverse event was reported on Apr 28, 2009 by a Male patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , weighting 167.6 lb, Patient had the following side effects: chronic lymphocytic leukaemia.

6171464-0 | Chronic Lymphocytic Leukaemia, Lymphadenopathy, Lymphocytosis
on Apr 21, 2009 Male patient from FRANCE , weighting 167.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: chronic lymphocytic leukaemia, lymphadenopathy, lymphocytosis. Romiplostim dosage: .

6164373-4 | Cardio-respiratory Arrest
on Apr 17, 2009 Female patient from FRANCE , weighting 121.3 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest. Romiplostim dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), NEXIUM (View Nexium Review and Nexium Label ), CELLCEPT (View Cellcept Review and Cellcept Label ).

6164370-9 | Ecchymosis, Petechiae, Polyneuropathy, Purpura, Sciatic Nerve Neuropathy, Therapeutic Response Decreased
Patient was taking Romiplostim (View Usage). Patient had the following side effects: ecchymosis, petechiae, polyneuropathy, purpura, sciatic nerve neuropathy, therapeutic response decreased on Apr 10, 2009 from FRANCE Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), MABTHERA (View Mabthera Review and Mabthera Label ), NEORAL (View Neoral Review and Neoral Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CELIPROLOL (View Celiprolol Review and Celiprolol Label ), PNEUMOCOCCAL VACCINE (View Pneumococcal Vaccine Review and Pneumococcal Vaccine Label ), INFLUENZA VACCINE (View Influenza Vaccine Review and Influenza Vaccine Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6156586-2 | Bicytopenia, Myelofibrosis
Adverse event was reported on Apr 09, 2009 by a Male patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: CANADA , weighting 191.8 lb, After Romiplostim was administered, patient had the following side effects: bicytopenia, myelofibrosis. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6156583-7 | Chronic Lymphocytic Leukaemia
on Apr 07, 2009 Male patient from FRANCE , 89 years of age, weighting 167.6 lb, was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: chronic lymphocytic leukaemia. Romiplostim dosage: .

6130149-7 | Septic Shock
on Mar 16, 2009 Male patient from FRANCE , weighting 211.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient had the following side effects: septic shock. Romiplostim dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), XATRAL (View Xatral Review and Xatral Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6130137-0 | Atrioventricular Block Complete
Patient was taking Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: atrioventricular block complete on Mar 11, 2009 from FRANCE Additional patient health information: Male patient , weighting 220.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), CALCITE (View Calcite Review and Calcite Label ), ACTONEL (View Actonel Review and Actonel Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), INIPOMP (View Inipomp Review and Inipomp Label ), ELISOR (View Elisor Review and Elisor Label ). Patient was hospitalized.

6120675-9 | Accidental Overdose, Incorrect Dose Administered, Thrombocythaemia
Adverse event was reported on Mar 06, 2009 by a Female patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , weighting 220.5 lb, Patient experienced the following unwanted or unexpected effects: accidental overdose, incorrect dose administered, thrombocythaemia. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ATACAND (View Atacand Review and Atacand Label ).

6114473-X | Epistaxis
on Mar 03, 2009 Male patient from UNITED STATES , weighting 151.2 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient had the following side effects: epistaxis. Romiplostim dosage: . Patient was hospitalized.

6112729-8 | Megakaryocytes Increased, Thrombocytopenia
on Mar 02, 2009 Male patient from UNITED STATES , weighting 307.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: megakaryocytes increased, thrombocytopenia. Romiplostim dosage: . During the same period patient was treated with CORGARD (View Corgard Review and Corgard Label ), DECADRON (View Decadron Review and Decadron Label ), IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), TYLENOL (View Tylenol Review and Tylenol Label ), PROTONIX (View Protonix Review and Protonix Label ), ATIVAN (View Ativan Review and Ativan Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), LASIX (View Lasix Review and Lasix Label ).

6103263-X | Platelet Count Decreased, Pruritus
Patient was taking Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, pruritus on Feb 24, 2009 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: .

6100973-5 | Cardio-respiratory Arrest
Adverse event was reported on Feb 23, 2009 by a Female patient taking Romiplostim (View Usage) (Dosage: ) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , weighting 121.3 lb, Patient had the following side effects: cardio-respiratory arrest.

6098507-7 | Therapeutic Response Decreased
on Feb 20, 2009 Male patient from FRANCE , weighting 198.4 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). After Romiplostim was administered, patient had the following side effects: therapeutic response decreased. Romiplostim dosage: . During the same period patient was treated with IMMUNOGLOBULINS (View Immunoglobulins Review and Immunoglobulins Label ), MABTHERA (View Mabthera Review and Mabthera Label ), NEORAL (View Neoral Review and Neoral Label ).

6098500-4 | Myalgia, Overdose
on Feb 23, 2009 Female patient from FRANCE , weighting 169.8 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Romiplostim (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia, overdose. Romiplostim dosage: .

6093472-0 | Septic Shock
Patient was taking Romiplostim (View Usage). Patient had the following side effects: septic shock on Feb 17, 2009 from FRANCE Additional patient health information: Male patient , weighting 211.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Romiplostim dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), XATRAL (View Xatral Review and Xatral Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).